Diclazuril

Spezifikationen

101831-37-2CAS-Nummer

640-372-7EG-Nummer

2-(4-chlorophenyl)-2-[2,6-dichloro-4-(3,5-dioxo-1,2,4-triazin-2-yl)phenyl]acetonitrileIUPAC-Name

C17H9Cl3N4O2Chemische Formel

407.6 g/molMolekulargewicht

DICLAZURIL; 101831-37-2; Clinacox; Vecoxan; Nuoqiu; Diclazurilo; Diclazurilum; DTXSID4046787; Diclazuril for veterinary use; NSC-759642; K110K1B1VE; R64,433; P-64433; 2,6-dichloro-alpha-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)benzeneacetonitrile; Benzeneacetonitrile, 2,6-dichloro-alpha-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-; DTXCID2026787; R-64-433; Protazil; 2,6-Dichloro-alpha-(4-chlorophenyl)-4-[4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl]benzeneacetonitrile; Clinacox 0.2%; RefChem:55000; 2-(4-chlorophenyl)-2-(2,6-dichloro-4-(3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazin-2-yl)phenyl)acetonitrile; 4-chlorophenyl (2,6-dichloro-4-(4,5-dihydro-3H-3,5-dioxo-1,2,4-triazin-2-yl)pheny l) acetonitrile; R-64433; 2-(4-chlorophenyl)-2-[2,6-dichloro-4-(3,5-dioxo-1,2,4-triazin-2-yl)phenyl]acetonitrile; MFCD00867203; 2-(4-chlorophenyl)-2-(2,6-dichloro-4-(3,5-dioxo-4,5-dihydro-1,2,4-triazin-2(3H)-yl)phenyl)acetonitrile; NCGC00168785-01; (p-Chlorophenyl)(2,6-dichloro-4-(4,5-dihydro-3,5-dioxo-as-triazin-2(3H)-yl)phenyl)acetonitrile; C17H9Cl3N4O2; DCZL; Diclazurilum [Latin]; Diclazurilo [Spanish]; SR-05000001484; UNII-K110K1B1VE; Diclazuril CRS; Diclazuril [USAN:USP:INN:BAN]; 2-(4-Chlorophenyl)-2-[2,6-dichloro-4-(3,5-dioxo-4,5-dihydro-1,2,4-triazin-2(3H)-yl)phenyl]acetonitrile; DRG-0079; Diclazuril (Standard); DICLAZURIL [MI]; Diclazuril (USP/INN); DICLAZURIL [INN]; DICLAZURIL [USAN]; DICLAZURIL [MART.]; DICLAZURIL [USP-RS]; orb320429; SCHEMBL126138; CHEMBL284733; orb1227147; orb1309527; DICLAZURIL [GREEN BOOK]; SCHEMBL27803573; CHEBI:95118; HY-B0357R; MSK7105; DICLAZURIL [USP MONOGRAPH]; GLXC-10872; HMS2089N18; HMS3655D11; HMS3715D21; HMS5080D17; Pharmakon1600-01502348; MSK7105-100AF; HY-B0357; MSK7105-1000AF; Tox21_112645; BDBM50088493; NSC759642; s2028; Diclazuril for system suitability CRS; AKOS005746928; CCG-213044; DB11398; EBC-656268; KS-5064; NSC 759642; SB18820; 2-[4-(4-chloro-alpha-cyanobenzyl)-3,5-dichlorophenyl]-1,2,4-triazine-3,5(2H,4H)-dione; NCGC00168785-02; NCGC00168785-03; NCGC00168785-09; AC-12108; AC-32608; SY067418; CAS-101831-37-2; D5457; NS00000688; SW199606-2; D03794; Diclazuril, VETRANAL(TM), analytical standard; AB01562968_01; AB01562968_02; F828067; DICLAZURIL FOR VETERINARY USE [EP MONOGRAPH]; Diclazuril Solution in Acetonitrile/DMF, 1000ug/mL; Diclazuril Solution in Acetonitrile/DMF, 100ug/mL; Q5273856; SR-05000001484-1; SR-05000001484-2; BRD-A06426627-001-03-5; BRD-A06426627-001-04-3; Diclazuril, United States Pharmacopeia (USP) Reference Standard; Diclazuril for system suitability, European Pharmacopoeia (EP) Reference Standard; (4-chlorophenyl)[2,6-dichloro-4-(3,5-dioxo-4,5-dihydro-1,2,4-triazin-2(3H)-yl)phenyl]acetonitrile; (RS)-(4-Chlorophenyl)[2,6-dichloro-4-(3,5-dioxo-4,5-dihydro-1,2,4-triazin-2(3H)-yl)phenyl]acetonitrile; 2,6-Dichloro-.alpha.-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)benzeneacetonitrile; 2,6-Dichloro-|_-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)benzeneacetonitrile; 2,6-Dichloro-a-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)benzeneacetonitrile; 2,6-dichloro-alpha-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitrile; BENZENEACETONITRILE, 2,6-DICHLORO-.ALPHA.-(4-CHLOROPHENYL)-4-(4,5-DIHYDRO-3,5-DIOXO-1,2,4-TRIAZIN-2(3H)-YL)-; Benzeneacetonitrile, 2,6-dichloro-|A-(4-chlorophenyl)-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-Synonyme